The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells

European Journal of Pharmacology

Volumn 674, Issue 2-3, 2012, Pages 104-111

  Fahlenkamp, Astrid V ^a,b   Rossaint, Rolf ^b   Haase, Hajo ^b   Al Kassam, Hussam ^b   Ryang, Yu Mi ^c   Beyer, Cordian ^a   Coburn, Mark ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Argon; Brain; Mitogen activated protein kinase; Noble gas

Indexed keywords

ARGON; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; GLIA CELL; IN VITRO STUDY; MICROGLIA; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ARGON; ASTROCYTES; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MICE; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84855539229     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.10.045     Document Type: Article

References (37)

1. Behnke, A.R., Yarbrough, O.D., 1939. Respiratory resistance, oil-water solubility, and mental effects of argon, compared with helium and nitrogen. Am. J. Physiol. 126, 409-415.
2. Bocchini, V., Mazzolla, R., Barluzzi, R., Blasi, E., Sick, P., Kettenmann, H., 1992. An immortalized cell line expresses properties of activated microglial cells. J. Neurosci. Res. 31, 616-621.
3. Coburn, M., Kunitz, O., Baumert, J.H., Hecker, K., Haaf, S., Zühlsdorff, A., Beeker, T., Rossaint, R., 2005. Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br. J. Anaesth. 94, 198-202. (Pubitemid 40220270)
4. Coburn, M., Maze, M., Franks, N.P., 2008. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit. Care Med. 36, 588-595. (Pubitemid 351158637)
5. De Rossi, L.W., Brueckmann, M., Rex, S., Barderschneider, M., Buhre, W., Rossaint, R., 2004. Xenon and isoflurane differentially modulate lipopolysaccharide-induced activation of the nuclear transcription factor KB and production of tumor necrosis factor-alpha and interleukin-6 in monocytes. Anesth. Analg. 98, 1007-1012. (Pubitemid 38405411)
6. Dickinson, R., Franks, N.P., 2010. Bench-to-bedside review: molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit. Care 14, 229.
7. Fahlenkamp, A.V., Coburn, M., Haase, H., Kipp, M., Ryang, Y.M., Rossaint, R., Beyer, C., 2011. Xenon enhances LPS-induced IL-1beta expression in microglia via the extracellular signal-regulated kinase 1/2 pathway. J. Mol. Neurosci. 45, 48-59.
8. Franks, N.P., Dickinson, R., de Sousa, S.L., Hall, A.C., Lieb, W.R., 1998. How does xenon produce anaesthesia? Nature 396, 324. (Pubitemid 28557385)
9. Gehrmann, J., Matsumoto, Y., Kreutzberg, G.W., 1995. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev. 20, 269-287.
10. Gordon, A., 1991. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 201, 477-482.
11. Guha, M., Mackman, N., 2001. LPS induction of gene expression in human monocytes. Cell. Signal. 13, 85-94. (Pubitemid 32222977)
12. Jawad, N., Rizvi, M., Gu, J., Adeyi, O., Tao, G., Maze, M., Ma, D., 2009. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci. Lett. 460, 232-236.
13. Jung, W.K., Lee, D.Y., Park, C., Choi, Y.H., Choi, I., Park, S.G., Seo, S.K., Lee, S.W., Yea, S.S., Ahn, S.C., Lee, C.M., Park, W.S., Ko, J.H., Choi, I.W., 2010. Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases. Br. J. Pharmacol. 159, 1274-1285.
14. Koblin, D.D., Fang, Z., Eger II, E.I., Laster, M.J., Gong, D., Ionescu, P., Halsey, M.J., Trudell, J.R., 1998. Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics). Anesth. Analg. 87, 419-424. (Pubitemid 28369104)
15. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
16. Lawrence, J.H., Loomis, W.F., Tobias, C.A., Turpin, F.H., 1946. Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. J. Physiol. 105, 197-204.
17. Loetscher, P.D., Rossaint, J., Rossaint, R., Weis, J., Fries, M., Fahlenkamp, A., Ryang, Y.M., Grottke, O., Coburn, M., 2009. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit. Care 13, R206.
18. Ma, D., Lim, T., Xu, J., Tang, H., Wan, Y., Zhao, H., Hossain, M., Maxwell, P.H., Maze, M., 2009. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J. Am. Soc. Nephrol. 20, 713-720.
19. Mio, Y., Shim, Y.H., Richards, E., Bosnjak, Z.J., Pagel, P.S., Bienengraeber, M., 2009. Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats. Anesth. Analg. 108, 858-866.
20. Misiak, M., Singh, S., Drewlo, S., Beyer, C., Arnold, S., 2010. Brain region-specific vulnerability of astrocytes in response to 3-nitropropionic acid ismediated by cytochrome c oxidase isoform expression. Cell Tissue Res. 341, 83-93.
21. Pagel, P.S., Krolikowski, J.G., Shim, Y.H., Venkatapuram, S., Kersten, J.R., Weihrauch, D., Warltier, D.C., Pratt Jr., P.F., 2007. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth. Analg. 105, 562-569. (Pubitemid 47300827)
22. Qian, L., Wei, S.J., Zhang, D., Hu, X., Xu, Z., Wilson, B., El-Benna, J., Hong, J.S., Flood, P.M., 2008. Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J. Immunol. 181, 660-668.
23. Riedel, E., 1990. Anorganische Chemie, second ed. Walter de Gruyter, Berlin/New York. 361.
24. Rizvi, M., Jawad, N., Vizcaychipi, M.P., Maze, M., Ma, D., 2010. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp. Biol. Med. (Maywood) 235, 886-891.
25. Rossaint, R., Reyle-Hahn, M., Schulte Am Esch, J., Scholz, J., Scherpereel, P., Vallet, B., Giunta, F., Del Turco, M., Erdmann, W., Tenbrinck, R., Hammerle, A.F., Nagele, P., Xenon Study Group, 2003. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 98, 6-13. (Pubitemid 36043402)
26. Rousseau, S., Papoutsopoulou, M., Symons, A., Cook, D., Lucocq, J.M., Prescott, A.R., O'Garra, A., Ley, S.C., Cohen, P., 2008. TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF α in LPS-stimulated macrophages. J. Cell. Sci. 121, 149-154. (Pubitemid 351228446)
27. Ruzicka, J., Benes, J., Bolek, L., Markvartova, V., 2007. Biological effects of noble gases. Physiol. Res. 56, S39-S44.
28. Ryang, Y.M., Fahlenkamp, A.V., Rossaint, R., Wesp, D., Loetscher, P.D., Beyer, C., Coburn, M., 2011. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit. Care Med. 39, 1448-1453.
29. Scherle, P.A., Jones, E.A., Favata, M.F., Daulerio, A.J., Covington, M.B., Nurnberg, S.A., Magolda, R.L., Trzaskos, J.M., 1998. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J. Immunol. 161, 5681-5686. (Pubitemid 28519136)
30. Sidoryk-Wegrzynowicz, M., Wegrzynowicz, M., Lee, E., Bowman, A.B., Aschner, M., 2011. Role of astrocytes in brain function and disease. Toxicol. Pathol. 39, 115-123.
31. Singh, S., Misiak, M., Beyer, C., Arnold, S., 2010. Brain region specificity of 3-nitropropionic acid-induced vulnerability of neurons involves cytochrome c oxidase. Neurochem. Int. 57, 297-305.
32. Subramaniam, S., Unsicker, K., 2010. ERK and cell death: ERK 1/2 in neuronal death. FEBS J. 227, 22-29.
33. Trudell, J.R., Koblin, D.D., Eger II, E.I., 1998. A molecular description of how noble gases and nitrogen bind to a model site of anesthetic action. Anesth. Analg. 87, 411-418. (Pubitemid 28369103)
34. Weber, N.C., Toma, O., Wolter, J.I., Obal, D., Müllenheim, J., Preckel, B., Schlack, W., 2005. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br. J. Pharmacol. 144, 123-132. (Pubitemid 40188554)
35. Weber, N.C., Stursberg, J., Wirthle, N.M., Toma, O., Schlack, W., Preckel, B., 2006a. Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. Br. J. Anaesth. 97, 298-306. (Pubitemid 44295664)
36. Weber, N.C., Toma, O., Damla, H., Wolter, J.I., Schlack, W., Preckel, B., 2006b. Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1. Eur. J. Pharmacol. 539, 1-9. (Pubitemid 44208811)
37. Yarin, Y.M., Amarjargal, N., Fuchs, J., Haupt, H., Mazurek, B., Morozova, S.V., Gross, J., 2005. Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat's organ of Corti. Hear. Res. 201, 1-9. (Pubitemid 40255539)